glp-1 receptor agonists adverse effects glp 1 agonist long term side Overdose risks increase as demand for injectable weight-loss drugs on the rise, research finds The expanding role of GLP-1

Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut

ICP, intracranial pressure

Effect of bimagrumab vs placebo on body fat mass among adults with type 2 diabetes and obesity: a phase 2 randomized clinical trial

We all work together as a team to share information and insights internally, lean on each others expertise, educate each patient, and make personalized health recommendations based on the unique needs of the individual

For weight loss specifically, Phase 2 trial data suggests retatrutide produces greater average weight loss (22-24%) compared to tirzepatide (18-22%) at maximum doses